Parameters of inhibition of HIV-1 infection by small anionic microbicides

Antiviral Research

Volumn 73, Issue 1, 2007, Pages 60-68

  Vzorov, Andrei N ^a   Bozja, Jadranka ^a   Dixon, Dabney W ^b   Marzilli, Luigi G ^c   Compans, Richard W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

HIV; Normal vaginal flora; Topical microbicide

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; MICROBICIDE; PHTHALOCYANINE DERIVATIVE; PORPHYRIN DERIVATIVE; SULFONATED COPPER PHTHALOCYANINE; SULFONATED NICKEL PHTHALOCYANINE; SULFONATED PHTHALOCYANINE; SULFONATED TETRAANTHRACENYLPORPHYRIN; SULFONATED TETRANAPHTHYLPORPHYRIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; BACTERIAL FLORA; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PH; PRIORITY JOURNAL; VAGINA FLORA; VIRUS INACTIVATION; VIRUS TRANSMISSION;

ANIONS; ANTI-HIV AGENTS; CELL LINE; CELLS, CULTURED; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INDOLES; LACTOBACILLUS; LYMPHOCYTES; MICROBIAL SENSITIVITY TESTS; PORPHYRINS; STRUCTURE-ACTIVITY RELATIONSHIP; VAGINA;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33846135716     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.07.008     Document Type: Article

References (39)

1. Anderson R.A., Feathergill K.A., Diao X.H., Cooper M.D., Kirkpatrick R., Herold B.C., Doncel G.F., Chany C.J., Waller D.P., Rencher W.F., and Zaneveld L.J. Preclinical evaluation of sodium cellulose sulfate (Ushercell) as a contraceptive antimicrobial agent. J. Androl. 23 (2002) 426-438
2. Antonio M.A., Hawes S.E., and Hillier S.L. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J. Infect. Dis. 180 (1999) 1950-1956
3. Bartz S.R., and Vodicka M.A. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 12 (1997) 337-342
4. Bobardt M.D., Armand-Ugon M., Clotet I., Zhang Z., David G., Este J.A., and Gallay P.A. Effect of polyanion-resistance on HIV-1 infection. Virology 325 (2004) 389-398
5. Bozja J., Yi K., Shafer W.M., and Stojiljkovic I. Porphyrin-based compounds exert antibacterial action against the sexually transmitted pathogens Neisseria gonorrhoeae and Haemophilus ducreyi. Int. J. Antimicrob. Agents 24 (2004) 578-584
6. Chackerian B., Long E.M., Luciw P.A., and Overbaugh J. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J. Virol. 71 (1997) 3932-3939
7. Clarke J.G., Peipert J.F., Hillier S.L., Heber W., Boardman L., Moench T.R., and Mayer K. Microflora changes with the use of a vaginal microbicide. Sex. Transm. Dis. 29 (2002) 288-293
8. Debnath A.K., Jiang S., Strick N., Lin K., Haberfield P., and Neurath A.R. Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1. J. Med. Chem. 37 (1994) 1099-1108
9. Derdeyn C.A., Decker J.M., Sfakianos J.N., Wu X., O'Brien W.A., Ratner L., Kappes J.C., Shaw G.M., and Hunter E. Sensitivity of HIV type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74 (2000) 8358-8367
10. Dezzutti C.S., James V.N., Ramos A., Sullivan S.T., Siddig A., Bush T.J., Grohskopf L.A., Paxton L., Subbarao S., and Hart C.E. In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission. Antimicrob. Agents Chemother. 48 (2004) 3834-3844
11. Dixon D.W., Gill A.F., Giribabu L., Vzorov A.N., Alam A.B., and Compans R.W. Sulfonated naphthyl porphyrins as agents against HIV-1. J. Inorg. Biochem. 99 (2005) 813-821
12. Greenhead P., Hayes P., Watts P.S., Laing K.G., Griffin G.E., and Shattock R.J. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J. Virol. 74 (2000) 5577-5586
13. Harrison P.F., Rosenberg Z., and Bowcut J. Topical microbicides for disease prevention: status and challenges. Clin. Infect. Dis. 36 (2003) 1290-1294
14. Herold B.C., Bourne N., Marcellino D., Kirkpatrick R., Strauss D.M., Zaneveld L.J., Waller D.P., Anderson R.A., Chany C.J., Barham B.J., Stanberry L.R., and Cooper M.D. Poly(sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases. J. Infect. Dis. 181 (2000) 770-773
15. Hillier S.L. Presented at the Advances in AIDS Vaccine Development. Bethesda, MD (1996)
16. Hoffman N.G., Seillier-Moiseiwitsch F., Ahn J., Walker J.M., and Swanstrom R. Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop. J. Virol. 76 (2002) 3852-3864
17. Keller M.J., Klotman M.E., and Herold B.C. Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus. Am. J. Reprod. Immunol. 49 (2003) 279-284
18. Kimpton J., and Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66 (1992) 2232-2239
19. Lederman M.M., Offord R.E., and Hartley O. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat. Rev. Immunol. 6 (2006) 371-382
20. Maguire R.A., Zacharopoulos V.R., and Phillips D.M. Carrageenan-based nonoxynol-9 spermicides for prevention of sexually transmitted infections. Sex. Transm. Dis. 25 (1998) 494-500
21. McLean N.W., and Rosenstein I.J. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. J. Med. Microbiol. 49 (2000) 543-552
22. Moulard M., Lortat-Jacob H., Mondor I., Roca G., Wyatt R., Sodroski J., Zhao L., Olson W., Kwong P.D., and Sattentau Q.J. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J. Virol. 74 (2000) 1948-1960
23. Neurath A.R., Strick N., and Debnath A.K. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120. J. Mol. Recognit. 8 (1995) 345-357
24. Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijn P., Desmyter J., and De Clercq E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20 (1988) 309-321
25. Pope M., and Haase A.T. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat. Med. 9 (2003) 847-852
26. Profy A.T., Sonderfan A.J., and Bourne N. PRO 2000 gel, a potential topical microbicide for HIV prevention, can block infection by other sexually tramsmitted disease pathogens. Proceedings of the 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3 (1998) 233-237
27. Ray N., and Doms R.W. HIV-1 coreceptors and their inhibitors. Curr. Top. Microbiol. Immunol. 303 (2006) 97-120
28. Scordi-Bello I.A., Mosoian A., He C., Chen Y., Cheng Y., Jarvis G.A., Keller M.J., Hogarty K., Waller D.P., Profy A.T., Herold B.C., and Klotman M.E. Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action. Antimicrob. Agents Chemother. 49 (2005) 3607-3615
29. Shafer W.M., Qu X., Waring A.J., and Lehrer R.I. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. U.S.A. 95 4 (1998) 1829-1833
30. Shattock R.J., and Doms R.W. AIDS models: microbicides could learn from vaccines. Nat. Med. 8 (2002) 425
31. Smith A.E., and Helenius A. How viruses enter animal cells. Science 304 (2004) 237-242
32. Stone A. Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Nat. Rev. Drug Discov. 1 (2002) 977-985
33. Song R., Witvrouw M., Schols D., Robert A., Balzarini J., DeClercq E., Bernadou J., and Meunier B. Anti-HIV activities of anionic metalloporphyrins and related compounds. Antivir. Chem. Chemother. 8 (1997) 85-97
34. Vasquez A., Jakobsson T., Ahrne S., Forsum U., and Molin G. Vaginal Lactobacillus flora of healthy Swedish women. J. Clin. Microbiol. 40 (2002) 2746-2749
35. Vicenzi E., Gatti A., Ghezzi S., Oreste P., Zoppetti G., and Poli G. Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives. AIDS 17 (2003) 177-181
36. Vzorov A.N., and Compans R.W. Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization. J. Virol. 74 (2000) 8219-8225
37. Vzorov A.N., Dixon D.W., Trommel J.S., Marzilli L.G., and Compans R.W. Inactivation of human immunodeficiency virus type 1 by porphyrins. Antimicrob. Agents Chemother. 46 (2002) 3917-3925
38. Vzorov A.N., Marzilli L.G., Compans R.W., and Dixon D.W. Prevention of HIV-1 infection by phthalocyanines. Antivir. Res. 59 (2003) 99-109
39. Vzorov A.N., Gernert K.M., and Compans R.W. Multiple domains of the SIV Env protein determine virus replication efficiency and neutralization sensitivity. Virology 332 (2005) 89-101